Literature DB >> 17540406

Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat.

Kanchan Anand1, Antje Schulte, Koh Fujinaga, Klaus Scheffzek, Matthias Geyer.   

Abstract

The positive transcription elongation factor b (P-TEFb) is an essential regulator of viral gene expression during the life cycle of human immunodeficiency virus type 1 (HIV-1). Its cyclin T1 subunit forms a ternary complex with the viral transcriptional transactivator (Tat) protein and the transactivation response (TAR) RNA element thereby activating cyclin dependent kinase 9 (Cdk9), which stimulates transcription at the level of chain elongation. We report the structure of the cyclin box domain of human cyclin T1 at a resolution of 2.67 A. The structure was obtained by crystallographic analysis of a fusion protein composed of cyclin T1 linked to the transactivator protein Tat from equine infectious anemia virus (EIAV), which is functionally and structurally related to HIV-1 Tat. The conserved cyclin box domain of cyclin T1 exhibits structural features for interaction with physiological binding partners such as Cdk9. A recognition site for Cdk/Cyclin substrates is partly covered by a cyclin T-specific insert, suggesting specific interactions with regulatory factors. The previously identified Tat/TAR recognition motif (TRM) forms a C-terminal helix that is partly occluded in the cyclin box repeat interface, while cysteine 261 is accessible to form an intermolecular zinc finger with Tat. Residues of the TRM contribute to a positively charged groove that may directly attract RNA molecules. The EIAV Tat protein instead appeared undefined from the electron density map suggesting that it is highly disordered. Functional experiments confirmed the TAR binding properties of the fusion protein and suggested residues on the second cyclin box repeat to contribute to Tat stimulated transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540406      PMCID: PMC1987359          DOI: 10.1016/j.jmb.2007.04.077

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

Review 1.  Recycling the cell cycle: cyclins revisited.

Authors:  Andrew W Murray
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Structural basis for CDK6 activation by a virus-encoded cyclin.

Authors:  Ursula Schulze-Gahmen; Sung-Hou Kim
Journal:  Nat Struct Biol       Date:  2002-03

Review 4.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

5.  A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells.

Authors:  Koh Fujinaga; Dan Irwin; Ran Taube; Fan Zhang; Matthias Geyer; B Matija Peterlin
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.

Authors:  Bryan M Wittmann; Koh Fujinaga; Huayun Deng; Ndiya Ogba; Monica M Montano
Journal:  Oncogene       Date:  2005-08-25       Impact factor: 9.867

7.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1.

Authors:  Chandreyee Das; Stephen P Edgcomb; Ralph Peteranderl; Lily Chen; Alan D Frankel
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

9.  Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation.

Authors:  Katrin Kaehlcke; Alexander Dorr; Claudia Hetzer-Egger; Veronique Kiermer; Peter Henklein; Martina Schnoelzer; Erwann Loret; Philip A Cole; Eric Verdin; Melanie Ott
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

10.  Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.

Authors:  Alastair I H Murchie; Ben Davis; Catherine Isel; Mohammad Afshar; Martin J Drysdale; Justin Bower; Andrew J Potter; Ian D Starkey; Terry M Swarbrick; Shabana Mirza; Catherine D Prescott; Philippe Vaglio; Fareed Aboul-ela; Jonathan Karn
Journal:  J Mol Biol       Date:  2004-02-20       Impact factor: 5.469

View more
  12 in total

1.  The folding competence of HIV-1 Tat mediated by interaction with TAR RNA.

Authors:  Jung Min Kim; Hee Sun Choi; Baik Lin Seong
Journal:  RNA Biol       Date:  2017-04-18       Impact factor: 4.652

Review 2.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

3.  Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.

Authors:  Takayuki Hamasaki; Mika Okamoto; Masanori Baba
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

4.  The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.

Authors:  Sonja Baumli; Graziano Lolli; Edward D Lowe; Sonia Troiani; Luisa Rusconi; Alex N Bullock; Judit E Debreczeni; Stefan Knapp; Louise N Johnson
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 5.  Tetartohedral twinning could happen to you too.

Authors:  Pietro Roversi; Eric Blanc; Steven Johnson; Susan Mary Lea
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

6.  A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.

Authors:  Alona Kuzmina; Nina Verstraete; Sigal Galker; Maayan Maatook; Olivier Bensaude; Ran Taube
Journal:  Retrovirology       Date:  2014-07-01       Impact factor: 4.602

7.  Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor.

Authors:  Marina R Alexander; Adam K Wheatley; Rob J Center; Damian F J Purcell
Journal:  Nucleic Acids Res       Date:  2010-01-13       Impact factor: 16.971

8.  Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.

Authors:  Julie K Jadlowsky; Masanori Nojima; Antje Schulte; Matthias Geyer; Takashi Okamoto; Koh Fujinaga
Journal:  Retrovirology       Date:  2008-07-11       Impact factor: 4.602

9.  Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent.

Authors:  Afzal Hussain; Chandan Kumar Verma; Usha Chouhan
Journal:  Saudi J Biol Sci       Date:  2015-10-22       Impact factor: 4.219

10.  The CDK9 tail determines the reaction pathway of positive transcription elongation factor b.

Authors:  Sonja Baumli; Alison J Hole; Lan-Zhen Wang; Martin E M Noble; Jane A Endicott
Journal:  Structure       Date:  2012-09-06       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.